Mealey's (March 15, 2021, 12:56 PM EDT) -- WASHINGTON, D.C. — Pursuant to Section 314(d) of the America Invents Act, the Federal Circuit U.S. Court of Appeals on March 12 said it lacks jurisdiction over an appeal by Mylan Laboratories Ltd. of a decision by the Patent Trial and Appeal Board to deny institution of inter partes review (IPR) of a patent directed to paliperidone palmitate for the treatment of adult schizophrenia....